5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer
Clinical trial NCT00308516 · COMPLETED
Trial details
- NCT number
- NCT00308516
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2009-04-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.